share_log

Healthcare Services Group Analyst Ratings

Benzinga ·  Oct 26, 2023 12:22
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/26/2023 61.37% Benchmark $18 → $16 Maintains Buy
08/31/2023 81.54% Benchmark → $18 Reiterates Buy → Buy
08/01/2023 61.37% RBC Capital → $16 Reiterates Outperform → Outperform
07/27/2023 61.37% RBC Capital $17 → $16 Maintains Outperform
04/28/2023 71.46% Credit Suisse $14 → $17 Maintains Neutral
04/27/2023 71.46% RBC Capital → $17 Reiterates → Outperform
03/24/2023 41.2% Jefferies $8.5 → $14 Upgrades Underperform → Hold
02/21/2023 81.54% Benchmark → $18 Reiterates → Buy
02/17/2023 41.2% Credit Suisse $12 → $14 Maintains Neutral
02/17/2023 71.46% RBC Capital $14 → $17 Upgrades Sector Perform → Outperform
02/13/2023 81.54% Benchmark → $18 Reiterates → Buy
10/20/2022 81.54% Benchmark → $18 Upgrades Hold → Buy
10/20/2022 21.03% Credit Suisse $15 → $12 Maintains Neutral
10/20/2022 41.2% RBC Capital $17 → $14 Maintains Sector Perform
04/21/2022 81.54% Credit Suisse $17 → $18 Maintains Neutral
04/21/2022 101.71% RBC Capital $17 → $20 Maintains Sector Perform
02/10/2022 36.16% Jefferies $19 → $13.5 Downgrades Hold → Underperform
10/22/2021 121.89% Credit Suisse $28 → $22 Maintains Neutral
10/21/2021 101.71% RBC Capital $29 → $20 Maintains Sector Perform
10/20/2021 William Blair Downgrades Outperform → Market Perform
07/22/2021 192.49% RBC Capital $30 → $29 Maintains Sector Perform
02/11/2021 212.66% Credit Suisse $32 → $31 Maintains Neutral
10/22/2020 162.23% Credit Suisse $31 → $26 Maintains Neutral
07/23/2020 192.49% Baird → $29 Downgrades Outperform → Neutral
07/07/2020 Northland Capital Markets Downgrades Outperform → Market Perform
07/06/2020 Benchmark Downgrades Buy → Hold
04/22/2020 172.31% Credit Suisse $32 → $27 Maintains Outperform
04/22/2020 111.8% RBC Capital $26 → $21 Maintains Sector Perform
04/20/2020 182.4% Baird → $28 Upgrades Neutral → Outperform
11/22/2019 162.23% RBC Capital → $26 Initiates Coverage On → Sector Perform
10/23/2019 242.91% Benchmark $37 → $34 Reiterates → Buy
07/24/2019 333.69% Sidoti & Co. $51 → $43 Maintains Buy
07/24/2019 253% Credit Suisse $41 → $35 Maintains Outperform
07/12/2019 222.74% Jefferies $40 → $32 Downgrades Buy → Hold
05/01/2019 202.57% Stifel $33 → $30 Maintains Sell

What is the target price for Healthcare Services Group (HCSG)?

The latest price target for Healthcare Services Group (NASDAQ: HCSG) was reported by Benchmark on October 26, 2023. The analyst firm set a price target for $16.00 expecting HCSG to rise to within 12 months (a possible 61.37% upside). 11 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Healthcare Services Group (HCSG)?

The latest analyst rating for Healthcare Services Group (NASDAQ: HCSG) was provided by Benchmark, and Healthcare Services Group maintained their buy rating.

When is the next analyst rating going to be posted or updated for Healthcare Services Group (HCSG)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Services Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Services Group was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.

Is the Analyst Rating Healthcare Services Group (HCSG) correct?

While ratings are subjective and will change, the latest Healthcare Services Group (HCSG) rating was a maintained with a price target of $18.00 to $16.00. The current price Healthcare Services Group (HCSG) is trading at is $9.91, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment